Biomark Diagnostics
  • Home
  • About BioMark
    • About Us
    • BioMark Technology
    • Publications & Scientific Posters
    • Awards and Achievements
    • Strategic Collaborations
    • Cancer Education Videos
  • Oncology Platform
    • Biomark SSAT1 Assay
    • BioMark Metabolic Panel
  • Investor Relations
    • Stock Quote
    • News Releases
    • Investment Highlights
    • Corporate Presentations and Communication
  • Bio-Stream Diagnostics
  • Recent Posts
  • Info & Contact

News Releases

« Back to News

BioMark To Be On CBC Early Edition

January 14, 2015

Press Release – BIOMARK TO BE ON CBC EARLY EDITION (PDF)

 

———————————————

< Biomark Announces A Partial Closing Private Placement BioMark Receives US Trading Symbol BMKDF from FINRA and Commences Trading in the USA >

ARCHIVES

  • 2020 News Release
  • 2019 News Release
  • 2018 News Release
  • 2017 News Release
  • 2016 News Release
  • 2015 News Release
  • 2014 News Release
Further information about BioMark is available under its profile on:
SEDAR website:
http://www.sedar.com
CSE website:
http://thecse.com

Sitemap

  • Home
  • About BioMark
    • About Us
    • BioMark Technology
    • Publications & Scientific Posters
    • Awards and Achievements
    • Strategic Collaborations
    • Cancer Education Videos
  • Oncology Platform
    • Biomark SSAT1 Assay
    • BioMark Metabolic Panel
  • Investor Relations
    • Stock Quote
    • News Releases
    • Investment Highlights
    • Corporate Presentations and Communication
  • Bio-Stream Diagnostics
  • Recent Posts
  • Info & Contact

Latest Posts

  • Alberta research to spot early stage lung cancer
  • A simple blood test to detect lung cancer
  • Long-Time Cardiologist Dr. Myron Weisfeldt Who “Changed Face of Hopkins” Receiving American Heart Association’s Distinguished Watkins-Saunders Award for Commitment to Overcoming Disparities
  • 3 Cancer Diagnostic Stocks To Watch Following Roche’s GenMark Buy
  • U of Alberta Researchers Win $120K Grant to Develop Metabolite-Based Lung Cancer Test

Site Policies

  • Terms and Conditions
  • Website and Privacy Policy

Contact Us

INVESTOR CORPORATE INQUIRES

RASHID A. BUX
  • CEO
  • 604.370.0779
  • info@biomarkdiagnostics.com

Copyright © 2019 BioMark Diagnostics Inc. All rights reserved.

Biomark Diagnostics

BioMark's mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.